HYDERGINE 0.5 Pill - white round
Generic Name: ergoloid mesylates
Pill with imprint HYDERGINE 0.5 is White, Round and has been identified as Hydergine 0.5 MG. It is supplied by Novartis Pharmaceuticals.
Hydergine is used in the treatment of Arteriosclerotic Dementia; Dementia; Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. FDA has not classified the drug for risk during pregnancy. Hydergine 0.5 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for HYDERGINE 0.5
Hydergine
- Generic Name
- ergoloid mesylates
- Imprint
- HYDERGINE 0.5
- Strength
- 0.5 MG
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00078-0051
See also:
Addyi
Addyi (flibanserin) is used to treat hypoactive sexual desire disorder (HSDD) in certain women ...
Ampyra
Ampyra (dalfampridine) is used to improve walking in patients with multiple sclerosis. Includes ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Bridion
Bridion is used for reversal of neuromuscular blockade, reversal of nondepolarizing muscle relaxants
Daybue
Daybue (trofinetide) is a synthetic analog of the amino‐terminal tripeptide of IGF-1 for the t ...
Inapsine
Inapsine is used for nausea/vomiting, nausea/vomiting, postoperative
Kisunla
Kisunla (donanemab) is a prescription medicine used for Alzheimer’s disease (AD) in patients with m ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
More about Hydergine (ergoloid mesylates)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.